Updated on 19 January 2026
New Approach Methodologies: patient-derived iPSC models
full professor at Department of Pharmaceutical Sciences, University of Latvia
Riga, Latvia
About
We have expertise in patient-derived iPSC generation and differentiation into skeletal myoblasts and myotubes for rare muscular dystrophies, including LGMDR1. Our work focuses on preclinical disease modelling to support personalised therapeutic development. We seek participation in a Horizon Europe consortium developing antisense oligonucleotide or base-editing approaches for rare inherited muscle diseases, contributing relevant cellular models for target validation and preclinical testing.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Henri Leinonen
Research Director, Research Council of Finland Fellow at University of Eastern Finland School of Pharmacy
Kuopio, Finland
Project cooperation
Expert on Histo-metabolic properties of skeletal muscle
Emiliana Giacomello
Assistant professor at University of Trieste
Trieste, Italy
Project cooperation
Patient-Derived iPSC & 3D Human Tissue NAM Platforms
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Sofia Aires Martins
Research Manager at Institute for Bioengineering and Biosciences
Lisboa, Portugal